VK

Vijaykumar Kantilal Nayani

Active Director Director DIN 06751333
DIN 06751333 First appointment Mar 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijaykumar Kantilal Nayani

Data last updated:

Vijaykumar Kantilal Nayani is a Director at Staphy Pharma Limited (since 2014). The company operates in Pharma.

DIN 06751333
Primary Designation Director
Industry Pharma
First Appointment 04 Mar 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Staphy Pharma Limited U51909GJ2014PLC078966
Director04 Mar 20142014Active

Board colleagues of Vijaykumar Kantilal Nayani

Directorship timeline

Open interactive timeline →
Staphy Pharma Limited
Premium access

Shareholding and investment profile for Vijaykumar Kantilal Nayani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijaykumar Kantilal Nayani

Vijaykumar Kantilal Nayani currently holds 1 directorship: Staphy Pharma Limited (Director, since 04 Mar 2014).

Vijaykumar Kantilal Nayani was first appointed on 04 Mar 2014 as Director at Staphy Pharma Limited.

The current boards of Vijaykumar Kantilal Nayani's companies include Becharlal Vishram Dadga (Staphy Pharma Limited), Bharatkumar Becharlal Patel (Staphy Pharma Limited), Dakshaben Bharatkumar Patel (Staphy Pharma Limited), Kantilal Hansraj Patel (Staphy Pharma Limited), Kruti Vijay Nayani (Staphy Pharma Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available